Westford, MA – According to filings with the U.S. Securities and Exchange Commission, Lotus Parent dba Cynosure is raising $26,730,384.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Michael Davin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Lotus Parent dba Cynosure
We are leaders, innovators, developers, and best-in-class creators of energy-based aesthetic and medical treatment systems. Cynosure develops and manufactures a diverse range of leading treatment applications for hair removal, skin revitalization, scar reduction, gynecological health, body contouring, and more. Our innovative products are used worldwide by practitioners, physicians, and aesthetic business owners to help enhance their offerings while providing the latest treatments to patients. Contact our team about how Cynosure can help you grow and succeed. With our comprehensive array of laser and RF technologies as well as technical, clinical and support services, Cynosure helps providers maximize growth and opportunities. While providing patients with the cutting edge treatments and services they deserve. Cynosure continues to be an industry leader in energy-based systems representing advanced levels of solid state liquid and semiconductor technologies. We are constantly looking forward to stay one step ahead of the industry while bringing patients and providers the latest in treatments.

To learn more about Lotus Parent dba Cynosure, visit http://www.cynosure.com/

Contact:
Michael Davin, Chief Executive Officer
800-886-2966
mdavin@cynosure.com
https://www.linkedin.com/in/michael-davin-91b46110/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved